No Approval for Rifaximin in IBS

(MedPage Today) — The FDA has indicated that, before the antibiotic drug rifaximin (Xifaxan) can be approved for treating irritable bowel syndrome, its manufacturer must provide data on how the agent should be used in retreating patients with recurrent symptoms, the company said.

Post a Comment

Comments are closed.